OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis, anticancer evaluation and docking studies of novel adamantanyl-1,3,4-oxadiazol hybrid compounds as Aurora-A kinase inhibitors
Areej M. Jaber, Mohammed M. Al-Mahadeen, Raed A. Al‐Qawasmeh, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 11, pp. 2394-2404
Open Access | Times Cited: 5
Areej M. Jaber, Mohammed M. Al-Mahadeen, Raed A. Al‐Qawasmeh, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 11, pp. 2394-2404
Open Access | Times Cited: 5
Showing 5 citing articles:
Synthesis, molecular docking, and anti-inflammatory evaluation of novel 4-(benzo[d][1,3]dioxol-5-yloxy)-N,N-2-yn-1-amine derivatives as potent cysteinyl leukotriene receptor (CysLT2) antagonists
Areej M. Jaber, Mohammed M. Al-Mahadeen, Belal O. Al-Najjar, et al.
Pharmacia (2025) Vol. 72, pp. 1-11
Open Access
Areej M. Jaber, Mohammed M. Al-Mahadeen, Belal O. Al-Najjar, et al.
Pharmacia (2025) Vol. 72, pp. 1-11
Open Access
Advances in the Design, Discovery, and optimization of aurora kinase inhibitors as anticancer agents
Anita Verma, Pradhuman Bharatiya, Aashish Jaitak, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access
Anita Verma, Pradhuman Bharatiya, Aashish Jaitak, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access
Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity
Mohammed M. Al-Mahadeen, Areej M. Jaber, Belal O. Al-Najjar, et al.
Current Organic Synthesis (2024) Vol. 22, Iss. 3, pp. 410-418
Closed Access | Times Cited: 1
Mohammed M. Al-Mahadeen, Areej M. Jaber, Belal O. Al-Najjar, et al.
Current Organic Synthesis (2024) Vol. 22, Iss. 3, pp. 410-418
Closed Access | Times Cited: 1
The crystal structure of 1-(1-adamantan-1-yl)ethyl-3-(3-methoxyphenyl)thiourea, C20H28N2OS
Shahnez Chaouch, Mohamed El‐Naggar, Ihsan A. Shehadi, et al.
Zeitschrift für Kristallographie - New Crystal Structures (2024) Vol. 239, Iss. 3, pp. 581-583
Open Access
Shahnez Chaouch, Mohamed El‐Naggar, Ihsan A. Shehadi, et al.
Zeitschrift für Kristallographie - New Crystal Structures (2024) Vol. 239, Iss. 3, pp. 581-583
Open Access
Synthesis, evaluation, and docking study of adamantyl-1,3,4-oxadiazol hybrid compounds as CaMKIIδ kinase inhibitor
Mohammed M. Al-Mahadeen, Areej M. Jaber, Raed A. Al‐Qawasmeh, et al.
Journal of Chemical Research (2024) Vol. 48, Iss. 3
Closed Access
Mohammed M. Al-Mahadeen, Areej M. Jaber, Raed A. Al‐Qawasmeh, et al.
Journal of Chemical Research (2024) Vol. 48, Iss. 3
Closed Access
Recent advancements in mechanistic Research, therapeutic Potential, and Structure-Activity relationships of Aurora kinase inhibitors in cancer therapies
Ghanshyam Teli, Lalmohan Maji, Rohit Pal, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107976-107976
Closed Access
Ghanshyam Teli, Lalmohan Maji, Rohit Pal, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107976-107976
Closed Access
